Popovits Kimberly J 4
4 · Kiniksa Pharmaceuticals International, plc · Filed Aug 1, 2025
Insider Transaction Report
Form 4
Popovits Kimberly J
Director
Transactions
- Exercise/Conversion
Class A Ordinary Share
2025-07-30$15.47/sh+18,760$290,217→ 77,054 total - Exercise/Conversion
Class A Ordinary Share
2025-07-30$29.90/sh−64,508$1,928,789→ 12,546 total - Exercise/Conversion
Share Option
2025-07-30−18,760→ 0 totalExercise: $15.47Exp: 2029-05-28→ Class A Ordinary Shares (18,760 underlying) - Exercise/Conversion
Class A Ordinary Share
2025-07-30$10.36/sh+45,748$473,949→ 58,294 total - Exercise/Conversion
Share Option
2025-07-30−45,748→ 0 totalExercise: $10.36Exp: 2028-02-29→ Class A Ordinary Shares (45,748 underlying)
Footnotes (2)
- [F1]This transaction was executed in multiple trades through a broker-dealer at prices ranging between $29.66 and $30.07. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- [F2]The option is fully vested and exercisable.